In our study, preoperative blood and tumor levels of VCAM-1 and ICAM-1 were lower in high SCS patients compared to low-medium SCS cases, while VCAM-1 levels in ascitic fluid were elevated in high SCS patients. This evidence concerns the gene ICAM1 and neoplasm.